The 15th Shijiazhuang Natural Extracts and Pharmaceutical Raw Materials Exhibition in 2025

Date: April 24-26, 2025 Location: Shijiazhuang International Convention and Exhibition Center

preface:

The 14th Five Year Plan and the 2035 Vision Outline propose to accelerate the development of industries such as biomedicine, biological breeding, biomaterials, and bioenergy, and to expand and strengthen the bioeconomy. The biopharmaceutical industry is a strategic emerging industry that is related to national economy, people's livelihood, and national security, covering multiple aspects such as biotechnology industry, pharmaceutical industry, and biomedical engineering industry.

In recent years, guided by favorable policies, China's biopharmaceutical industry has entered the "fast lane" of development, and a series of new products and services have provided new assistance to safeguard people's lives and health. Looking at the industry, there has been a significant increase in R&D investment across the industry, with thousands of new drugs entering clinical trials and hundreds of new drugs undergoing international multicenter clinical trials. The number of approved new drugs is increasing day by day. Looking at enterprises, traditional pharmaceutical companies are accelerating their transformation pace, constantly laying out innovative drug research and development, and a large number of emerging biotechnology companies are being established and growing rapidly. These innovative entities are important forces in promoting the development of biopharmaceutical innovation.

With the high attention of the government, continuous market growth, and new breakthroughs in technology, the demand for biopharmaceuticals in both domestic and international markets in China has experienced explosive growth. As of 2023, the market size of China's biopharmaceutical industry will reach 4.39 trillion yuan.

At present, China's biopharmaceutical industry has initially formed an industrial cluster centered on Beijing Tianjin Hebei, Yangtze River Delta, Chengdu Chongqing Economic Circle, Guangdong Hong Kong Macao Greater Bay Area, etc. Among them, Beijing Tianjin Hebei has become an important gathering place and strong driving force for the development of China's biopharmaceutical industry through the complementary and cooperative development of industries in Beijing, Tianjin, and Hebei.

In order to establish a cooperation and exchange platform between natural extracts and pharmaceutical raw materials and biotechnology enterprises such as biopharmaceuticals, health products, functional foods, cosmetics, etc., seize the opportunities of the new round of technological revolution and industrial transformation, and strive to create a new highland for biopharmaceutical innovation gathering, "Natural Extracts and Pharmaceutical Raw Materials" will be one of the characteristic theme exhibition areas of the 15th China (Shijiazhuang) Biopharmaceutical Industry Expo 2025, providing a cooperation and exchange platform for technical exchange, product display, and trade negotiations for exhibitors and attendees.

◆ Schedule:

Forum Time: April 24, 2025, 9:30-11:30 AM, 14:00-4:30 PM

April 25, 2025, 9:00-11:00 AM, 13:30-15 PM thirty

Exhibition:

Registration and Exhibition: April 22-23, 2025 (9:00-17:00)

Exhibition time: April 24-26, 2025 (9:00-16:30)

◆ Display scope:

1. Plant extract raw materials: vegetable, fruit extract, plant, herbal extract, fungus extract, antioxidant, anti-aging extract, beverage raw material extract, food additive extract, weight loss plant extract, plant extract consumer goods extract, production auxiliary materials, corn starch, bee products, pectin, pearls, fatty acids, hormones, dietary fiber, spices, chondroitin sulfate, bovine colostrum, beneficial bacteria, silk peptides, sheep placenta extract, polyphenols, etc.

2. Healthy and innovative raw materials for marine organisms: animal extracts, mineral extracts, animal proteins, biotechnology, etc.

3. Medical raw materials: medical and health raw materials, plant medicine extracts, functional food raw materials, health products, dietary supplement raw materials, anti-cancer extracts, heat clearing and detoxifying extracts, cardiovascular and cerebrovascular extracts, antibacterial, anti-inflammatory and antiviral extracts, immune enhancement extracts, blood pressure lowering and blood sugar lowering extracts.

4. Packaging material: medicinal glass; Bottle caps and stoppers; Aluminum foil, aluminum-plastic packaging, and aluminum products; Packaging printing; Capsules, gelatin; Medicinal plastic bottles; Plastic tray; Medicinal PVC hard sheet; Medicinal polyethylene bag; Medicinal composite film; Medicinal tubing; Raw material packaging barrels; desiccant; Clean clothing and materials; Aerosol packaging; Injection packaging materials; Other packaging materials.

5. Pharmaceutical equipment: complete chemical equipment, spray dryer, reaction kettle, falling film evaporator, vacuum decompression concentration tank, Chinese herbal medicine extraction and concentration unit, external circulation concentration tank, multi-function extraction tank, API equipment, preparation equipment, pharmaceutical packaging machinery, pharmaceutical automation and digital technology, laboratory equipment and consumables, fluid equipment, environmental protection and purification equipment, pharmaceutical grinding equipment, pharmaceutical water equipment, drying equipment, refrigeration equipment, fermentation equipment, Chinese medicine equipment, pharmaceutical logistics equipment, health care products soft capsule equipment, etc.

◆ Simultaneous activities:

The 15th China (Shijiazhuang) Biomedical Industry Expo

The 15th China (Shijiazhuang) Biochemical Instruments and Laboratory Equipment (Consumables) Exhibition in 2025

The 15th China (Shijiazhuang) Pharmaceutical Equipment and Packaging Machinery Exhibition in 2025

Chemical Pharmaceutical Intelligent Manufacturing and Quality Control Technology Forum

Seminar on Technological Innovation and Industrial Development in the Pharmaceutical Industry

◆ Audience composition

Biotechnology such as food, drugs, cosmetics, health products, vaccines/antibodies, genetic engineering, traditional Chinese medicine, active pharmaceutical ingredients, biomedical enterprises, traditional Chinese medicine, natural medicine and health products, dual-use of medicine and food, and big health industry enterprises, universities/research institutes, hospitals/medical inspection institutions, pharmaceutical experimental testing units, industrial parks, government regulatory departments, industry associations/associations, trade institutions, life science and analytical equipment, diagnostic and testing equipment, facility design, protein drug companies, production solution providers, HVAC cleanroom equipment suppliers, laboratory equipment suppliers, contract service providers (CRO, CMO, CDMO), legal and compliance companies, third-party logistics, pharmaceutical cold chain companies, importers and exporters Distributors, wholesalers and retailers, etc.

Professional audience

- Heads of provincial and municipal health commissions, medical experts, health research institutions, medical laboratories, medical schools, research institutes, biomedicine, cross-border healthcare, anti-aging companies, etc;

- Deans, hospital managers, oncologists, biotherapeutics, hematologists, pathologists, assisted reproductive systems, laboratory physicians, and experts and researchers from related fields in hospitals in various provinces and cities;

Professors, researchers, pharmacy majors, medical majors, immunology majors, etc. from well-known universities;

Enterprises in the upstream, midstream, and downstream industrial chains of the biopharmaceutical industry, etc;

- Innovative drug CEO and pharmaceutical company R&D leader: CRO、CMO、 Experts in the fields of antibody immunotherapy drug development, immune cell therapy and product development, oncolytic viruses, small molecule immunotherapy drugs, cell therapy, and regenerative medicine

- Upstream suppliers of cell and tumor antibody immunotherapy, diagnostic reagent and equipment service providers, etc;

Government agencies and representatives, industrial parks, investment promotion bureaus, investment incubation institutions, consulting and training institutions, insurance, family offices, wealth inheritance, private banks, lawyers, intellectual property, securities companies, etc.

• Telephone:18222670120
• Truename:Chen Aifei
• Mobile:18222670120
• Address:No. 9 Heyang Road, Zhengding New District, Shijiazhuang City, Hebei Province

The information on this site comes from the network and related members, and the website has done its duty to review it. Due to the uncontrollability of the process of organizing the exhibition, some of the exhibition information in the station may change the subject matter, Extending or cancelling the event, please exhibitors and visitors must check with each other again before exhibiting! All the exhibitions in this site are not hosted/co-organized or organized, if there are any disputes during the exhibition, please hold the main responsibility of the exhibition organization! QQ Email: 523138820@qq.com WeChat: 523138820 Mobile: 15313206870